Arcturus Therapeutics Holdings Inc. (ARCT) — Financial statements
Income statement, balance sheet, and cash flow for Arcturus Therapeutics Holdings Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 67↓51.4% | 138↓12.3% | 158↓23.3% | 206↑1564.8% | 12 | |
| Cost of Revenue | 3 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 64↓53.6% | 138↓12.3% | 158↓23.3% | 206↑1564.8% | 12 | |
| Operating Expenses | ||||||
| R&D Expenses | 112↓42.5% | 195↑1.6% | 192↑30.0% | 148↓15.0% | 174 | |
| General & Administrative Expenses | 46↓12.8% | 53↓0.1% | 53↑14.8% | 46↑11.1% | 41 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 46↓12.8% | 53↓0.1% | 53↑14.8% | 46↑11.1% | 41 | |
| Other Expenses | -19↓37.5% | -14↓53.8% | -9↓3609.4% | -0.24 | 0.00 | |
| Operating Expenses | 139↓40.5% | 234↓0.8% | 236↑21.9% | 194↓10.1% | 215 | |
| Total Costs & Expenses | 142↓39.3% | 234↓0.8% | 236↑21.9% | 194↓10.1% | 215 | |
| Operating Results | ||||||
| Operating Income | -75↑21.7% | -96↓22.3% | -78↓742.2% | 12↑106.0% | -203 | |
| Depreciation & Amortization | 3↓14.6% | 4↑19.9% | 3↑93.6% | 2↑28.0% | 1 | |
| EBITDA | -72↑7.1% | -77↓220.3% | -24↓276.3% | 14↑106.8% | -202 | |
| EBIT | -75↑7.4% | -81↓198.4% | -27↓322.7% | 12↑106.0% | -203 | |
| Interest & Other Income | ||||||
| Net Interest Income | 10↓33.6% | 15↓8.4% | 17↑4050.5% | -0.42↑78.1% | -2 | |
| Interest Income | 10↓33.6% | 15↓12.5% | 17↑572.6% | 3↑242.8% | 0.75 | |
| Interest Expense | 0.00 | 0.00↓100.0% | 0.77↓74.4% | 3↑12.2% | 3 | |
| Non-Operating Income | 0.00↑100.0% | -15↑71.2% | -51 | 0.00 | 0.00 | |
| Other Income / Expenses | 9↓37.7% | 15↓70.7% | 50↑3382.1% | -2↓86.5% | -0.82 | |
| Income Before Tax | -66↑18.7% | -81↓190.2% | -28↓362.0% | 11↑105.2% | -204 | |
| Income Tax Expense | 0.00↑100.0% | -0.00↓100.2% | 2↑41.7% | 1 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -66↑18.7% | -81↓172.3% | -30↓417.9% | 9↑104.6% | -204 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -66↑18.7% | -81↓172.3% | -30↓417.9% | 9↑104.6% | -204 | |
| Bottom-Line Net Income | -66↑18.7% | -81↓172.3% | -30↓417.9% | 9↑104.6% | -204 | |
| EPS (Basic) | -2.40↑20.0% | -3.00↓167.9% | -1.12↓420.0% | 0.35↑104.5% | -7.74 | |
| EPS (Diluted) | -2.40↑20.0% | -3.00↓167.9% | -1.12↓420.0% | 0.35↑104.5% | -7.74 | |
| Weighted Average Shares | 27↑1.4% | 27↑1.4% | 27↑0.7% | 26↑0.5% | 26 | |
| Weighted Average Diluted Shares | 27↑1.4% | 27↑1.4% | 27↓1.7% | 27↑2.9% | 26 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.